Advertisement

Advertisement

SILO Stock Latest News

Silo Pharma Implements Reverse Stock Split and Restructures Capital

Company AnnouncementsSilo Pharma Implements Reverse Stock Split and Restructures Capital

Silo Pharma Inc trading halted, news pending

PremiumThe Fly

Silo Pharma Inc trading halted, news pending

2d ago

Silo Pharma Announces 1-for-15 Reverse Stock Split

PremiumCompany Announcements

Silo Pharma Announces 1-for-15 Reverse Stock Split

4d ago

Silo Pharma files provisional patent for ibogaine-based therapeutics

PremiumThe Fly

Silo Pharma files provisional patent for ibogaine-based therapeutics

28d ago

Psychedelic: Jefferies initiates Compass Pathways with a Buy rating

PremiumThe Fly

Psychedelic: Jefferies initiates Compass Pathways with a Buy rating

28d ago

Psychedelic: FDA awards Compass Pathways priority review voucher

PremiumThe FlyPsychedelic: FDA awards Compass Pathways priority review voucher

1M ago

Silo Pharma expands into AI technology with Qwikagents asset purchase

The Fly

Silo Pharma expands into AI technology with Qwikagents asset purchase

1M ago

Psychedelic: AtaiBeckley reports publication of BPL-003 study results

The Fly

Psychedelic: AtaiBeckley reports publication of BPL-003 study results

2M ago

Silo Pharma gets European Patent Office allowance for PTSD prevention therapy

PremiumThe Fly

Silo Pharma gets European Patent Office allowance for PTSD prevention therapy

2M ago

Silo Pharma Acquires QwikAgents Platform Using Equity

PremiumCompany Announcements

Silo Pharma Acquires QwikAgents Platform Using Equity

2M ago

Silo Pharma Announces $1 Million Stock Repurchase Program

PremiumCompany Announcements

Silo Pharma Announces $1 Million Stock Repurchase Program

3M ago

Silo Pharma announces $1M share repurchase program

PremiumThe Fly

Silo Pharma announces $1M share repurchase program

3M ago

Silo Pharma receives Notice of Allowance in Japan for SPC-15

PremiumThe FlySilo Pharma receives Notice of Allowance in Japan for SPC-15

4M ago

Silo Pharma executes LOI with Allucent for Phase 1 development of SPC-15

The Fly

Silo Pharma executes LOI with Allucent for Phase 1 development of SPC-15

5M ago

Silo Pharma Receives Extended Nasdaq Compliance Grace Period

Company Announcements

Silo Pharma Receives Extended Nasdaq Compliance Grace Period

5M ago

Psychedelic: Clearmind reports results from first cohort in AUD trial

PremiumThe Fly

Psychedelic: Clearmind reports results from first cohort in AUD trial

7M ago

Silo Pharma partners with Allucent for planned FDA IND application for SPC-15

PremiumThe Fly

Silo Pharma partners with Allucent for planned FDA IND application for SPC-15

7M ago

Silo Pharma selects AlphaLedger’s T12 Fund for tokenized RWA investments

PremiumThe Fly

Silo Pharma selects AlphaLedger’s T12 Fund for tokenized RWA investments

7M ago

Silo Pharma Shareholders Approve Key Proposals at Annual Meeting

PremiumCompany Announcements

Silo Pharma Shareholders Approve Key Proposals at Annual Meeting

7M ago

Psychedelic: Clearmind enrolls last patient in first cohort of CMND-100 trial

PremiumThe FlyPsychedelic: Clearmind enrolls last patient in first cohort of CMND-100 trial

7M ago

Silo Pharma provides update on SPC-15 advancement, digital asset program

The Fly

Silo Pharma provides update on SPC-15 advancement, digital asset program

7M ago

Psychedelic: PharmAla launches portal for MDMA prescribers, therapists

The Fly

Psychedelic: PharmAla launches portal for MDMA prescribers, therapists

8M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >